161 related articles for article (PubMed ID: 37562987)
1. Preservation of fertility in female patients with hematologic diseases.
Antunes MB; Cardeal SP; Magalhães M; Vale-Fernandes E; Barreiro M; Sá R; Sousa M
Blood Rev; 2023 Nov; 62():101115. PubMed ID: 37562987
[TBL] [Abstract][Full Text] [Related]
2. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
3. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
[TBL] [Abstract][Full Text] [Related]
4. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
5. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
6. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
7. Preservation of fertility in patients with hematological malignancies.
Ashizawa M; Kanda Y
Jpn J Clin Oncol; 2020 Jul; 50(7):729-742. PubMed ID: 32419028
[TBL] [Abstract][Full Text] [Related]
8. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
9. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
10. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
11. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
12. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
[TBL] [Abstract][Full Text] [Related]
14. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
15. Fertility preservation before and after cancer treatment in children, adolescents, and young adults.
Yang EH; Strohl HB; Su HI
Cancer; 2024 Feb; 130(3):344-355. PubMed ID: 37962199
[TBL] [Abstract][Full Text] [Related]
16. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
17. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
18. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
[TBL] [Abstract][Full Text] [Related]
19. Added Benefit of Immature Oocyte Maturation for Fertility Preservation in Women with Malignancy.
Cohen Y; Tannus S; Volodarsky-Perel A; Son WY; Tulandi T; Buckett W
Reprod Sci; 2020 Dec; 27(12):2257-2264. PubMed ID: 32617879
[TBL] [Abstract][Full Text] [Related]
20. Hematological Malignancies and Fertility.
Ozdemir ZN; Bozdag SC
Adv Exp Med Biol; 2020; 1288():103-115. PubMed ID: 32124411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
